<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37735229</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>21</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Venous blood parameters in determination of respiratory impairment in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>15695</StartPage><MedlinePgn>15695</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">15695</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-42075-4</ELocationID><Abstract><AbstractText>This study aimed to investigate the relationship between venous blood parameters and respiratory functions in patients with amyotrophic lateral sclerosis (ALS) and develop a model to predict respiratory impairment for individual patients with ALS. A total of 416 ALS patients were included in the study, and various hematologic and biochemical laboratory parameters as well as demographic and clinical factors were collected and compared. A multivariable logistic regression model was constructed to assess the association between FVC and venous blood biomarkers and clinical factors. The results showed that along with onset age, bulbar-onset, disease duration, BMI, eosinophil count (EO#), basophil count (BASO#), creatinine (CREA), uric acid (URCI) and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol (LDL/HDL) ratio were associated with reduced FVC. The area under the ROC curve is 0.735 for the test set and 0.721 for the validation set. The study also developed a relatively acceptable model for predicting respiratory impairment in ALS patients. These findings suggest that EO#, BASO#, CREA, URIC and LDL/HDL ratio can be useful in assessing FVC in ALS and can be easily accessible, accurate, and low-cost parameters.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>He</LastName><ForeName>Xianghua</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, West China Hospital, Sichuan University, 37, Guo Xue Xiang, Chengdu, 610041, Sichuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Jiangbin Hospital, No 85 Hedi Road, Guangxi Zhuang Autonomous Region, Nanning, 530021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yang</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Continuing Medical Education, West China Hospital, Sichuan University, 37, Guo Xue Xiang, Chengdu, 610041, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Jiaming</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Medical College, West China Hospital, Sichuan University, 37, Guo Xue Xiang, Chengdu, 610041, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Hongyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, West China Hospital, Sichuan University, 37, Guo Xue Xiang, Chengdu, 610041, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Xiaolin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Affiliated Yan'An Hospital of Kunming Medical University, Kunming, 650051, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Quanzhen</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, West China Hospital, Sichuan University, 37, Guo Xue Xiang, Chengdu, 610041, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Qiuyan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, West China Hospital, Sichuan University, 37, Guo Xue Xiang, Chengdu, 610041, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Caiyou</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangbin Hospital, No 85 Hedi Road, Guangxi Zhuang Autonomous Region, Nanning, 530021, China. cyhu.hua@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yanming</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, West China Hospital, Sichuan University, 37, Guo Xue Xiang, Chengdu, 610041, Sichuan, China. neuroxym999@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008076">Cholesterol, HDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008078">Cholesterol, LDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007958" MajorTopicYN="N">Leukocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008076" MajorTopicYN="N">Cholesterol, HDL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008078" MajorTopicYN="N">Cholesterol, LDL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>22</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37735229</ArticleId><ArticleId IdType="pmc">PMC10514276</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-42075-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-42075-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: An update of recent literature. Curr. Opin. Neurol. 2019;32(5):771&#x2013;776. doi: 10.1097/WCO.0000000000000730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Braak H, Del Tredici K, Lemon R, Ludolph A, Kiernan M. Cortical influences drive amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2017;88(11):917&#x2013;924. doi: 10.1136/jnnp-2017-315573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315573</ArticleId><ArticleId IdType="pubmed">28710326</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr E, Logroscino G, Robberecht W, Shaw P, Simmons Z, van den Berg L. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriani M, Desnuelle C. Care management in amyotrophic lateral sclerosis. Revue neurologique. 2017;173(5):288&#x2013;299. doi: 10.1016/j.neurol.2017.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2017.03.031</ArticleId><ArticleId IdType="pubmed">28461024</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P, Abrahams S, Borasio G, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison K, Petri S, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur. J. Neurol. 2012;19(3):360&#x2013;375. doi: 10.1111/j.1468-1331.2011.03501.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;ffner R, Zach N, Norel R, Hawe J, Schoenfeld D, Wang L, Li G, Fang L, Mackey L, Hardiman O, et al. Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression. Nat. Biotechnol. 2015;33(1):51&#x2013;57. doi: 10.1038/nbt.3051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3051</ArticleId><ArticleId IdType="pubmed">25362243</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Bovio G, Canosa A, Bertuzzo D, Galmozzi F, Cugnasco P, Clerico M, De Mercanti S, Bersano E, et al. Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: A population-based study. JAMA Neurol. 2014;71(9):1134&#x2013;1142. doi: 10.1001/jamaneurol.2014.1129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1129</ArticleId><ArticleId IdType="pubmed">25048026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda K, Hirayama T, Takazawa T, Kawabe K, Iwasaki Y. Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: A cross-sectional study. Intern. Med. (Tokyo, Japan) 2012;51(12):1501&#x2013;1508. doi: 10.2169/internalmedicine.51.7465.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.51.7465</ArticleId><ArticleId IdType="pubmed">22728481</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H, Garofalo D, Santella R, Sorenson E, Oskarsson B, Fernandes J, Andrews H, Hupf J, Gilmore M, Heitzman D, et al. Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis. Amyotroph. Later. Scler. Frontotemporal Degener. 2020;21:263&#x2013;272. doi: 10.1080/21678421.2020.1746810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1746810</ArticleId><ArticleId IdType="pmc">PMC7373369</ArticleId><ArticleId IdType="pubmed">32276554</ArticleId></ArticleIdList></Reference><Reference><Citation>Che&#x142;stowska B, Ku&#x17a;ma-Kozakiewicz M. Biochemical parameters in determination of nutritional status in amyotrophic lateral sclerosis. Neurol. Sci. 2020;41(5):1115&#x2013;1124. doi: 10.1007/s10072-019-04201-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-04201-x</ArticleId><ArticleId IdType="pubmed">31897946</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgadinho J, Pronto-Laborinho A, Concei&#xe7;&#xe3;o V, Gromicho M, Pinto S, Swash M, de Carvalho M. Plasma creatinine level does not predict respiratory function in amyotrophic lateral sclerosis. J. Neuromuscul. Dis. 2021;8:795&#x2013;799. doi: 10.3233/JND-200583.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JND-200583</ArticleId><ArticleId IdType="pubmed">33646173</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Later. Scler. Other Mot. Neuron Disord. 2000;1(5):293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Al-Chalabi A, Filippi M, Hardiman O, Kaji R, Meininger V, Nakano I, Shaw P, Shefner J, van den Berg L, et al. The El Escorial criteria: Strengths and weaknesses. Amyotroph. Later. Scler. Frontotemporal Degener. 2015;16:1&#x2013;7. doi: 10.3109/21678421.2014.964258.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.964258</ArticleId><ArticleId IdType="pubmed">25482030</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson M, Pompei P, Ales K, MacKenzie C. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic Dis. 1987;40(5):373&#x2013;383. doi: 10.1016/0021-9681(87)90171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller M, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten C, Gustafsson P, et al. Standardisation of spirometry. Eur. Respir. J. 2005;26(2):319&#x2013;338. doi: 10.1183/09031936.05.00034805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.05.00034805</ArticleId><ArticleId IdType="pubmed">16055882</ArticleId></ArticleIdList></Reference><Reference><Citation>Wever A, Britton M, Hughes D, Van der Plas K, Wever-Hess J. Clinical evaluation of five spirometers. Monaghan M403, Pneumoscreen, Spirotron, Vicatest and Vitalograph. Eur. J. Respir. Dis. 1981;62(2):127&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">7238663</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt S, Balte P, Schwartz J, Cassano P, Couper D, Jacobs D, Kalhan R, O'Connor G, Yende S, Sanders J, et al. Discriminative accuracy of FEV1:FVC thresholds for COPD-related hospitalization and mortality. JAMA. 2019;321(24):2438&#x2013;2447. doi: 10.1001/jama.2019.7233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.7233</ArticleId><ArticleId IdType="pmc">PMC6593636</ArticleId><ArticleId IdType="pubmed">31237643</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Ilardi A, Cavallo E, Moglia C, Mutani R, Palmo A, Galletti R, Marinou K, Papetti L, et al. Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology. 2009;73(20):1681&#x2013;1685. doi: 10.1212/WNL.0b013e3181c1df1e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181c1df1e</ArticleId><ArticleId IdType="pubmed">19917991</ArticleId></ArticleIdList></Reference><Reference><Citation>Couratier P, Corcia P, Lautrette G, Nicol M, Preux P, Marin B. Epidemiology of amyotrophic lateral sclerosis: A review of literature. Revue neurologique. 2016;172(1):37&#x2013;45. doi: 10.1016/j.neurol.2015.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2015.11.002</ArticleId><ArticleId IdType="pubmed">26727307</ArticleId></ArticleIdList></Reference><Reference><Citation>Moglia C, Calvo A, Grassano M, Canosa A, Manera U, D'Ovidio F, Bombaci A, Bersano E, Mazzini L, Mora G, et al. Early weight loss in amyotrophic lateral sclerosis: Outcome relevance and clinical correlates in a population-based cohort. J. Neurol. Neurosurg. Psychiatry. 2019;90(6):666&#x2013;673. doi: 10.1136/jnnp-2018-319611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319611</ArticleId><ArticleId IdType="pubmed">30630957</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C, Wang L, Mao S, Zhang Y, Song L, Cai L, Tao Y. The clinical assessment of amyotrophic lateral sclerosis patients' prognosis by ZNF512B gene, neck flexor muscle power score and body mass index (BMI) BMC Neurol. 2018;18(1):211. doi: 10.1186/s12883-018-1219-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-018-1219-9</ArticleId><ArticleId IdType="pmc">PMC6299516</ArticleId><ArticleId IdType="pubmed">30567526</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo S, Steyn F, McCombe P. Body mass index and dietary intervention: Implications for prognosis of amyotrophic lateral sclerosis. J. Neurol. Sci. 2014;340:5&#x2013;12. doi: 10.1016/j.jns.2014.02.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.02.035</ArticleId><ArticleId IdType="pubmed">24629478</ArticleId></ArticleIdList></Reference><Reference><Citation>Requardt M, G&#xf6;rlich D, Grehl T, Boentert M. Clinical determinants of disease progression in amyotrophic lateral sclerosis-A retrospective cohort study. J. Clin. Med. 2021;10(8):1623. doi: 10.3390/jcm10081623.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10081623</ArticleId><ArticleId IdType="pmc">PMC8069893</ArticleId><ArticleId IdType="pubmed">33921250</ArticleId></ArticleIdList></Reference><Reference><Citation>Burney P, Patel J, Minelli C, Gnatiuc L, Amaral A, Kocaba&#x15f; A, Cherkaski H, Gulsvik A, Nielsen R, Bateman E, et al. Prevalence and population attributable risk for chronic airflow obstruction in a large multinational study. Am. J. Respir. Crit. Care Med. 2020;203:1353&#x2013;1365. doi: 10.1164/rccm.202005-1990OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202005-1990OC</ArticleId><ArticleId IdType="pmc">PMC8456536</ArticleId><ArticleId IdType="pubmed">33171069</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol. Rev. 2000;80(3):1107&#x2013;1213. doi: 10.1152/physrev.2000.80.3.1107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.2000.80.3.1107</ArticleId><ArticleId IdType="pubmed">10893433</ArticleId></ArticleIdList></Reference><Reference><Citation>Swaminathan R, Ho C, Chu L, Donnan S. Relation between plasma creatinine and body size. Clin. Chem. 1986;32(2):371&#x2013;373. doi: 10.1093/clinchem/32.2.371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/32.2.371</ArticleId><ArticleId IdType="pubmed">3943202</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutedja N, van der Schouw Y, Fischer K, Sizoo E, Huisman M, Veldink J, Van den Berg L. Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2011;82(6):638&#x2013;642. doi: 10.1136/jnnp.2010.236752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.236752</ArticleId><ArticleId IdType="pubmed">21471184</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar J, Bonnefont-Rousselot D, Bittar R, Seilhean D, Hauw J, Lacomblez L, Loeffler J, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70(13):1004&#x2013;1009. doi: 10.1212/01.wnl.0000285080.70324.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Korevaar D, Westerhof G, Wang J, Cohen J, Spijker R, Sterk P, Bel E, Bossuyt P. Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: A systematic review and meta-analysis. Lancet Respir. Med. 2015;3(4):290&#x2013;300. doi: 10.1016/S2213-2600(15)00050-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(15)00050-8</ArticleId><ArticleId IdType="pubmed">25801413</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche N, Chapman K, Vogelmeier C, Herth F, Thach C, Fogel R, Olsson P, Patalano F, Banerji D, Wedzicha J. Blood eosinophils and response to maintenance chronic obstructive pulmonary disease treatment data from the FLAME trial. Am. J. Respir. Crit. Care Med. 2017;195(9):1189&#x2013;1197. doi: 10.1164/rccm.201701-0193OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201701-0193OC</ArticleId><ArticleId IdType="pubmed">28278391</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A, Datta S, Weiss S, Tantisira K. Remission of persistent childhood asthma: Early predictors of adult outcomes. J. Allergy Clin. Immunol. 2019;143(5):1752&#x2013;1759.e1756. doi: 10.1016/j.jaci.2018.09.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.09.038</ArticleId><ArticleId IdType="pmc">PMC7061344</ArticleId><ArticleId IdType="pubmed">30445065</ArticleId></ArticleIdList></Reference><Reference><Citation>Watz H, Tetzlaff K, Wouters E, Kirsten A, Magnussen H, Rodriguez-Roisin R, Vogelmeier C, Fabbri L, Chanez P, Dahl R, et al. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: A post-hoc analysis of the WISDOM trial. Lancet Respir. Med. 2016;4(5):390&#x2013;398. doi: 10.1016/S2213-2600(16)00100-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(16)00100-4</ArticleId><ArticleId IdType="pubmed">27066739</ArticleId></ArticleIdList></Reference><Reference><Citation>Salter B, Nusca G, Tworek D, Oliveria J, Smith S, Watson R, Scime T, Obminski C, Sehmi R, Gauvreau G. Expression of activation markers in circulating basophils and the relationship to allergen-induced bronchoconstriction in subjects with mild allergic asthma. J. Allergy Clin. Immunol. 2016;137(3):936&#x2013;938.e937. doi: 10.1016/j.jaci.2015.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2015.08.024</ArticleId><ArticleId IdType="pubmed">26441227</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens W, Staudacher A, Hulse K, Poposki J, Kato A, Carter R, Suh L, Norton J, Huang J, Peters A, et al. Studies of the role of basophils in aspirin-exacerbated respiratory disease pathogenesis. J. Allergy Clin. Immunol. 2021;148(2):439&#x2013;449.e435. doi: 10.1016/j.jaci.2021.02.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2021.02.045</ArticleId><ArticleId IdType="pmc">PMC8355049</ArticleId><ArticleId IdType="pubmed">33819512</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunnon K, Ibrahim Z, Proitsi P, Lourdusamy A, Newhouse S, Sattlecker M, Furney S, Saleem M, Soininen H, K&#x142;oszewska I, et al. Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood. J. Alzheimer's Dis. JAD. 2012;30(3):685&#x2013;710. doi: 10.3233/JAD-2012-111592.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2012-111592</ArticleId><ArticleId IdType="pubmed">22466004</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>